Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients

Annals of Emergency Medicine

Volumn 62, Issue 1, 2013, Pages 80-88

  Dugas, Andrea Freyer ^a,b   Coleman, Sara ^b   Gaydos, Charlotte A ^a,b   Rothman, Richard E ^a   Frick, Kevin D ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; MOXIFLOXACIN; OSELTAMIVIR; ZANAMIVIR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC TEST; EMERGENCY WARD; HIGH RISK PATIENT; HUMAN; INFLUENZA; OTITIS MEDIA; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RESPIRATORY TRACT INFECTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINUSITIS; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIVIRAL AGENTS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; UNITED STATES;

EID: 84880823804     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2013.01.005     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention Seasonal influenza. 2011 http://www.cdc.gov/flu/about/qa/disease.htm Accessed March 12, 2013
2. W.W. Thompson, D.K. Shay, E. Weintraub Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
3. W.W. Thompson, D.K. Shay, E. Weintraub Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340
4. A.E. Fiore, A. Fry, D. Shay Centers for Disease Control and Prevention (CDC) Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Surveill Summ 60 2011 1 24
5. S.A. Harper, J.S. Bradley, J.A. Englund Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 48 2009 1003 1032
6. World Health Organization WHO recommendations on the use of rapid testing for influenza diagnosis http://www.who.int/influenza/resources/documents/rapid- testing/en/index.html Accessed March 12, 2013
7. F.G. Hayden, A.D. Osterhaus, J.J. Treanor Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections N Engl J Med 337 1997 874 880
8. A.S. Monto, D.M. Fleming, D. Henry Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections J Infect Dis 180 1999 254 261
9. K.G. Nicholson, F.Y. Aoki, A.D. Osterhaus Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial Lancet 355 2000 1845 1850
10. S. Heinonen, H. Silvennoinen, P. Lehtinen Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial Clin Infect Dis 51 2010 887 894
11. Centers for Disease Control and Prevention (CDC) Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States, 2009 MMWR Morb Mortal Wkly Rep 58 2009 826 829
12. A.S. Monto, S. Gravenstein, M. Elliott Clinical signs and symptoms predicting influenza infection Arch Intern Med 160 2000 3243 3247
13. A.R. Sambol, P.C. Iwena, M. Pieretti Validation of the Cepheid Xpert Flu: a real time RT-PCR detection panel for emergency use authorization J Clin Virol 48 2010 234 238
14. M.B. Rothberg, S. He, D.N. Rose Management of influenza symptoms in healthy adults J Gen Intern Med 18 2003 808 815
15. S.E. Talbird, A.J. Brogan, A.P. Winiarski Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States Am J Health Syst Pharm 66 2009 469 480
16. B.Y. Lee, S.M. McGlone, R.R. Bailey To test or to treat? an analysis of influenza testing and antiviral treatment strategies using economic computer modeling PLoS One 5 2010 E11284
17. M.B. Rothberg, S. Bellantonio, D.N. Rose Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy Ann Intern Med 139 5 pt 1 2003 321 329
18. J.E. Siegel, M.C. Weinstein, L.B. Russell Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341
19. R.S. Braithwaite, D.O. Meltzer, J.T.J. King What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 46 2008 349 356
20. J. Stein, J. Louie, S. Flanders Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults Ann Emerg Med 46 2005 412 419
21. B. Donner, S. Bader-Weder, R. Schwarz Safety profile of oseltamivir during the 2009 influenza pandemic Pharmacoepidemiol Drug Saf 20 2009 532 543
22. Hsieh Y-H, Kelen GD, Dugas AF, et al. Emergency department management of adult patients with a clinical diagnosis of influenza and provider's adherence to CDC guidance during the 2009 H1N1 Pandemic. West J Emerg Med. In press. doi: 10.5811/westjem.2012.11.12246.
23. F.M. Cox, M.M. Cobb, W.Q. Chua Cost of treating influenza in emergency department and hospital settings Am J Manag Care 6 2000 205 214
24. A. McGeer, K.A. Green, A. Plevneshi Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada Clin Infect Dis 45 2007 1568 1575
25. J. Lalezari, K. Campion, O. Keene Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials Arch Intern Med 161 2001 212 217
26. MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections Lancet 352 1998 1877 1881
27. A.D. Griffin, A.S. Perry, D.M. Fleming Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients Pharmacoeconomics 19 2001 293 301
28. N.A. Molinari, I.R. Ortega-Sanchez, M.L. Messonnier The annual impact of seasonal influenza in the US: measuring disease burden and costs Vaccine 25 2007 5086 5096
29. United States Department of Labor Consumer Price Index ftp://ftp.bls.gov/pub/special.requests/cpi/cpiai.txt Accessed March 12, 2013
30. Drug Topics Red Book 2011 Thomson Healthcare Montvale, NY
31. United States Department of Labor Occupational Employment Statistics. 2010 http://www.bls.gov/oes/current/oes-nat.htm#00-0000 Accessed March 12, 2013.
32. D.E. Noyola, G.J. Demmler Effect of rapid diagnosis on management of influenza A infections Pediatr Infect Dis J 19 2000 303 307
33. L. Kaiser, C. Wat, T. Mills Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations Arch Intern Med 163 2003 1667 1671
34. E.B. Popowitch, E. Rogers, M.B. Miller Retrospective and prospective verification of the Cepheid Xpert influenza virus assay J Clin Microbiol 49 2011 3368 3369
35. American Medical Association Current Procedural Terminology code: 99213. 2011 https://ocm.ama-assn.org/OCM/CPTRelativeValueSearchResults.do?locality= 39&keyword=99213 Accessed March 12, 2013